NPPA slashes prices on 33 FDCs drugs EP News Bureau Nov 15, 2023 This move affects pharma companies like JB Chemicals, Eris Lifesciences, Zydus Healthcare, Cipla, Sun Pharma, Sanofi India, and…
Cracking the code – Generic vs. Brand Medicines EP News Bureau Sep 12, 2023 Dr Suresh Saravdekar, Former Assistant Director, Ministry of Medical Education & Research and Honorary Consultant, Institute…
There should be a change in SOP parameters for evaluating FDCs: Dr RK Sanghavi Usha Sharma Mar 31, 2021 A sub-committee of DTAB has asked manufacturers of FDCs which were considered irrational by Prof Kokate Committee to present their…
Industry experts disagree with NPPA’s remark on FDCs Usha Sharma Nov 9, 2020 Experts say it is beyond the jurisdiction of NPPA